Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.95
-0.55 (-2.56%)
At close: Jul 22, 2025, 4:00 PM HKT
-2.56%
Market Cap4.51B
Revenue (ttm)n/a
Net Income (ttm)-179.03M
Shares Out198.91M
EPS (ttm)-0.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,600
Average Volume35,320
Open21.50
Previous Close21.50
Day's Range20.85 - 21.90
52-Week Range20.00 - 27.20
Beta-1.55
RSI46.69
Earnings DateAug 21, 2025

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 159
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.